Template:Guillain-Barré syndrome: Difference between revisions
Jump to navigation
Jump to search
(Created page with "{| class="infobox bordered" style="width: 15em; text-align: left; font-size: 90%; background:AliceBlue" |- | colspan="1" style="text-align:center; background:DarkGray" | '''G...") |
No edit summary |
||
(20 intermediate revisions by 8 users not shown) | |||
Line 16: | Line 16: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Guillain-Barré syndrome (patient information)|Patient | [[Guillain-Barré syndrome (patient information)|Patient Information]] | ||
|- | |- | ||
|- | |- | ||
Line 29: | Line 29: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Guillain-Barré syndrome historical perspective|Historical | [[Guillain-Barré syndrome historical perspective|Historical Perspective]] | ||
|- | |- | ||
! | ! | ||
Line 35: | Line 35: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Guillain-Barré syndrome | [[Guillain-Barré syndrome classification|Classification]] | ||
|- | |- | ||
! | ! | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Guillain-Barré syndrome | [[Guillain-Barré syndrome pathophysiology|Pathophysiology]] | ||
|- | |- | ||
! | ! | ||
Line 47: | Line 46: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Guillain-Barré syndrome | [[Guillain-Barré syndrome causes|Causes]] | ||
|- | |- | ||
! | ! | ||
Line 53: | Line 52: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Guillain-Barré syndrome | [[Differentiating Guillain-Barré syndrome from other diseases|Differentiating Guillain-Barré syndrome from other Diseases]] | ||
|- | |- | ||
! | ! | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Guillain-Barré syndrome | [[Guillain-Barré syndrome epidemiology and demographics|Epidemiology and Demographics]] | ||
|- | |- | ||
! | ! | ||
Line 65: | Line 63: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Guillain-Barré syndrome | [[Guillain-Barré syndrome risk factors|Risk Factors]] | ||
|- | |- | ||
! | ! | ||
Line 71: | Line 69: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Guillain-Barré syndrome | [[Guillain-Barré syndrome screening|Screening]] | ||
|- | |- | ||
! | ! | ||
Line 77: | Line 75: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Guillain-Barré syndrome | [[Guillain-Barré syndrome natural history, complications, and prognosis|Natural history, Complications, and Prognosis]] | ||
|- | |- | ||
! | ! | ||
Line 89: | Line 87: | ||
|- bgcolor="LightSkyBlue" | |- bgcolor="LightSkyBlue" | ||
! | ! | ||
[[Guillain-Barré syndrome history and symptoms|History | [[Guillain-Barré syndrome diagnostic study of choice|Diagnostic Study of Choice]] | ||
|- | |||
! | |||
|- bgcolor="LightSkyBlue" | |||
! | |||
[[Guillain-Barré syndrome history and symptoms|History and Symptoms]] | |||
|- | |- | ||
! | ! | ||
Line 101: | Line 105: | ||
|- bgcolor="LightSkyBlue" | |- bgcolor="LightSkyBlue" | ||
! | ! | ||
[[Guillain-Barré syndrome laboratory tests| | [[Guillain-Barré syndrome laboratory tests|Laboratory Findings]] | ||
|- | |- | ||
! | ! | ||
Line 113: | Line 117: | ||
|- bgcolor="LightSkyBlue" | |- bgcolor="LightSkyBlue" | ||
! | ! | ||
[[Guillain-Barré syndrome | [[Guillain-Barré syndrome X-ray|X-ray]] | ||
|- | |- | ||
! | ! | ||
Line 119: | Line 123: | ||
|- bgcolor="LightSkyBlue" | |- bgcolor="LightSkyBlue" | ||
! | ! | ||
[[Guillain-Barré syndrome | [[Guillain-Barré syndrome Echocardiography and Ultrasound|Echocardiography and Ultrasound]] | ||
|- | |- | ||
! | ! | ||
Line 125: | Line 129: | ||
|- bgcolor="LightSkyBlue" | |- bgcolor="LightSkyBlue" | ||
! | ! | ||
[[Guillain-Barré syndrome CT|CT]] | [[Guillain-Barré syndrome CT scan|CT scan]] | ||
|- | |- | ||
! | ! | ||
Line 131: | Line 135: | ||
|- bgcolor="LightSkyBlue" | |- bgcolor="LightSkyBlue" | ||
! | ! | ||
[[Guillain-Barré syndrome | [[Guillain-Barré syndrome MRI|MRI]] | ||
|- | |- | ||
! | ! | ||
Line 150: | Line 154: | ||
! | ! | ||
Treatment | Treatment | ||
|- | |- | ||
! | ! | ||
Line 173: | Line 171: | ||
|- bgcolor="PaleTurquoise" | |- bgcolor="PaleTurquoise" | ||
! | ! | ||
[[Guillain-Barré syndrome | [[Guillain-Barré syndrome Primary prevention|Primary Prevention]] | ||
|- | |- | ||
! | ! | ||
|- bgcolor="PaleTurquoise" | |- bgcolor="PaleTurquoise" | ||
Line 181: | Line 179: | ||
[[Guillain-Barré syndrome secondary prevention|Secondary Prevention]] | [[Guillain-Barré syndrome secondary prevention|Secondary Prevention]] | ||
|- | |- | ||
! | ! | ||
|- bgcolor="PaleTurquoise" | |- bgcolor="PaleTurquoise" | ||
Line 193: | Line 191: | ||
[[Guillain-Barré syndrome future or investigational therapies|Future or Investigational Therapies]] | [[Guillain-Barré syndrome future or investigational therapies|Future or Investigational Therapies]] | ||
|- | |- | ||
! | ! | ||
|- bgcolor="CadetBlue" | |||
! | |||
Case Studies | |||
|- | |||
! | |||
|- bgcolor="PaleTurquoise" | |||
! | |||
[[Guillain-Barré syndrome case study one|Case #1]] | |||
|- | |||
! | |||
|- bgcolor="PaleGoldenrod " | |- bgcolor="PaleGoldenrod " |
Latest revision as of 17:39, 20 December 2018
Guillain-Barré syndrome Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Guillain-Barré syndrome On the Web |
American Roentgen Ray Society Images of Guillain-Barré syndrome |
Risk calculators and risk factors for Guillain-Barré syndrome |